FILE PHOTO: A company logo is seen at the AstraZeneca FILE PHOTO: A company logo is seen at the AstraZeneca site in Macclesfield, Britain, May 11, 2021. REUTERS/Phil Noble Post navigation Previous: US FDA panel backs restricted use of AstraZeneca’s prostate cancer drug (April 28)
